George, Goldy C <br/><br/>
Improving attribution of adverse events in oncology clinical trials.  [electronic resource] 

 -  Cancer treatment reviews  Jun 2019 
 - 33-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1532-1967 
<br/><br/><label>Standard No.: </label>10.1016/j.ctrv.2019.04.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adverse Drug Reaction Reporting Systems<br/>Antineoplastic Agents--adverse effects<br/>Clinical Trials, Phase III as Topic--methods<br/>Drug Development--methods<br/>Humans<br/>Randomized Controlled Trials as Topic--methods